We could not find any results for:
Make sure your spelling is correct or try broadening your search.
-- New Phase 3 trial of Genasense(R) seeks to confirm benefit in melanoma BERKELEY HEIGHTS, N.J., Aug. 7 /PRNewswire-FirstCall/ -- Genta Incorporated (NASDAQ:GNTAD) today announced financial...
BERKELEY HEIGHTS, N.J., Aug. 2 /PRNewswire-FirstCall/ -- Genta Incorporated (NASDAQ:GNTAD) announced that the Company will release its second quarter 2007 financial results on Tuesday, August 7...
BERKELEY HEIGHTS, N.J., July 30 /PRNewswire-FirstCall/ -- Genta Incorporated (NASDAQ:GNTAD) announced today that the Company has been formally notified by NASDAQ that it has demonstrated...
AGENDA Trial Set to Confirm Findings in Marketing Application BERKELEY HEIGHTS, N.J., July 19 /PRNewswire-FirstCall/ -- Genta Incorporated (NASDAQ:GNTAD) announced today that it has received...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions